Last reviewed · How we verify

NCT05083793

the Effect of Pregabalin on Postoperative Pain and Opioid Consumption in Spine Surgery

Status unknown Phase 2 Last updated 19 October 2021
What this trial tests

Phase 2 trial testing Pregabalin 150mg in Postoperative Pain in 90 participants. Status unknown.

Timeline
1 April 2020
Primary endpoint
1 January 2022
1 January 2022

Quick facts

Lead sponsorAssiut University
PhasePhase 2
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment90
Start date1 April 2020
Primary completion1 January 2022
Estimated completion1 January 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 18 to 60, any sex, with Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The effect of pregabalin on post-operative pain and opioid consumption in spine surgery, a prospective, randomized, controlled study

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pregabalin 150mg

Trials testing the same drug.

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05083793.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing